ProKidney Corp. (PROK)
1.83
-0.02
(-1.08%)
USD |
NASDAQ |
Sep 10, 16:00
1.83
0.00 (0.00%)
After-Hours: 20:00
ProKidney Shareholders Equity (Quarterly) : -883.53M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -883.53M |
| March 31, 2026 | -1.024B |
| December 31, 2025 | -1.011B |
| September 30, 2025 | -1.008B |
| June 30, 2025 | -1.002B |
| March 31, 2025 | -998.55M |
| December 31, 2024 | -994.95M |
| September 30, 2024 | -979.71M |
| June 30, 2024 | -972.37M |
| March 31, 2024 | -1.096B |
| December 31, 2023 | -1.103B |
| Date | Value |
|---|---|
| September 30, 2023 | -1.093B |
| June 30, 2023 | -1.322B |
| March 31, 2023 | -1.602B |
| December 31, 2022 | -1.097B |
| September 30, 2022 | -1.096B |
| June 30, 2022 | 235.37M |
| March 31, 2022 | 237.64M |
| December 31, 2021 | 26.92M |
| September 30, 2021 | 243.69M |
| June 30, 2021 | 0.0197M |
| March 31, 2021 | 0.0198M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 249.02M |
| Total Liabilities (Quarterly) | 26.18M |
| Debt to Equity Ratio | -0.004 |
| Current Ratio | 8.356 |
| Net Debt Paydown Yield | -0.01% |